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Mental health and smoking cessation—a
population survey in England
Leonie S. Brose1,2* , Jamie Brown2,3,4 and Ann McNeill1,2
Abstract
Background: To reduce inequalities between individuals with and without mental health problems, a better
understanding is required of triggers and success of quit attempts among the third of smokers with mental health
problems. The aim was to assess whether there are differences by mental health status in (i) triggers for quit
attempts, (ii) use of evidence-based support (iii) and quit success.
Methods: Monthly cross-sectional household surveys of representative samples of the adult population in England.
In 2016/2017, 40,831 adults were surveyed; 1956 who had attempted to stop smoking cigarettes in the past year
were included. Logistic regressions assessed associations between mental health (ever diagnosis, past-year
treatment, past-month distress), triggers, support used and quit success, adjusting for sociodemographic and
smoking characteristics.
Results: Concern about future health, current health problems and expense of smoking were the most common
triggers overall. For respondents with an ever diagnosis, past-year treatment or serious past-month distress, quit
attempts were more frequently triggered by current health problems. Non-evidence-based support and e-cigarettes
were used most often, and this did not differ by mental health status. Respondents with an ever diagnosis and
moderate or serious distress were less likely to have used non-prescription nicotine replacement therapy (NRT).
Respondents with past-year treatment or serious distress were more likely to have used prescription medication/
behavioural support. Quit success did not differ by mental health status. Compared with non-evidence-based
support, non-prescription NRT conferred no benefit. There was some evidence that prescription medication/
behavioural support was beneficial (depending on outcome and adjustment, ORs ranged from 1.46, 95% CI 0.92–
2.31, to 1.69, 1.01–2.86). E-cigarettes were associated with higher success rates after adjustment for different
indicators of mental health (ORs ranged from 2.21, 1.64–2.98, to 2.25, 1.59–3.18).
Conclusions: Smokers with mental health problems were more likely to have attempted to quit because of health
problems and were more likely to have used gold standard support (medication and behavioural support) than
other smokers. E-cigarettes were strongly associated with increased success and were used similarly by those with
and without mental health problems, indicating that improved uptake of e-cigarettes for smoking cessation among
smokers with mental health problems could help address inequalities.
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Background
There are substantial inequalities in morbidity and pre-
mature mortality between individuals with mental health
problems and those without. Much of this inequality is
due to preventable risks such as smoking, excessive alco-
hol consumption, sleep disturbance, physical inactivity
and dietary risks [1–4]. Tobacco control strategies have
led to an overall decline in smoking prevalence in coun-
tries such as the UK and the United States of America
(US); however, there remains a large gap in smoking
prevalence between people with and without mental
health problems. Among those with a common mental
health disorder in England, smoking prevalence remains
around 50% higher [5], and this increases further for
more severe mental disorders [6]. Figures for the US also
show an increased burden of smoking among those with
mental health problems [7–9]. About one third of
smokers have a mental health problem [6, 10], and the
relationship between mental health and smoking is com-
plex and appears to be bidirectional [4, 11, 12]. Previous
research has consistently shown that smokers with mental
health problems on average smoke more heavily [5–7, 10]
and extract more nicotine from each cigarette than those
without mental health problems [6].
Successful smoking cessation is associated with subse-
quently improved physical and mental health [4, 13], reduced
financial stress and, for people on specific psychotropic medi-
cation, a reduction in dose and side effects [6, 11]. Surveys in
the UK and the US have consistently found negative associa-
tions between having mental health problems and having
quit smoking [5, 14, 15], although this association is attenu-
ated when taking heaviness of smoking into account [5]. In-
creased smoking cessation among smokers with mental
health problems would reduce significant avoidable costs to
the economy, consisting of direct medical costs, lost product-
ivity and premature mortality [16]. Thus, there is an urgent
need to improve cessation in this group as emphasised by a
cross-government outcomes strategy [17], the National Insti-
tute for Health and Care Excellence (NICE, [18]) and a Lan-
cet Psychiatry Commission [4].
In order to reduce the personal and societal inequal-
ities caused by smoking, each step of the quitting
process needs to be addressed [19] to help increase the
proportion of smokers with mental health problems who
quit successfully. An increase in quitting can be achieved
by increasing the frequency of quit attempts, e.g. by
effectively triggering attempts, and by increasing the
likelihood of success for each attempt by more frequent
use of evidence-based support. We have recently shown
that smokers with mental health problems in England
were more motivated to stop smoking and more likely
to attempt to stop than smokers without mental health
problems [10]. However, less than one third had
attempted to stop smoking in the past year, so further
evidence is needed on approaches which may help
increase attempts to stop smoking. Evidence for the
effectiveness of support indicates that varenicline is
more efficacious than bupropion or nicotine replace-
ment therapy (NRT) which in turn are more effective
than placebo [20–22] and that behavioural support in
addition to pharmacological support generally improves
outcomes [23], for those with and without mental health
problems.
There is little evidence to date on the extent to which
smokers with mental health problems use the most
effective support [21] and how different types of support
are associated with the success of attempts to stop
smoking in the real world.
Methods
Aims
This study aimed to address three research questions:
1. What are the most frequent triggers for quit
attempts in smokers who (a) have had a diagnosis
of a mental health problem, (b) have had treatment
for this mental health problem in the past year or
(c) have experienced moderate or serious
psychological distress in the past month? Does this
differ from smokers without mental health
problems?
2. Does the use of evidence-based smoking cessation
support differ in smokers with and without (a) a
diagnosis of a mental health problem, (b) past-year
treatment or (c) past-month distress?
3. Does the success of quit attempts with different
aids vary in smokers with and without (a) a
diagnosis of a mental health problem, (b) past-year
treatment or (c) past-month distress?
Design and setting
The present study used self-reported data from monthly
cross-sectional household surveys of representative sam-
ples of the population of adults in England collected as part
of the ongoing Smoking and Alcohol Toolkit Study. The
methodology for the Toolkit Study has been described in
detail by Fidler et al. [24], and to date, it has provided data
for approximately 85 peer-reviewed publications. Briefly,
each month (wave), a new sample of approximately 1700
adults aged 16 years or older in England completes a face-
to-face computer-assisted survey. After stratification by a
geo-demographic classification of the population, small
geographical areas containing approximately 300 house-
holds are allocated randomly. Interviewers visit households
within the random locality and conduct computer-assisted
face-to-face interviews with one member of a household in
those areas until a pre-specified quota tailored to the area
is fulfilled. This form of sampling has benefits over
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conventional quota sampling, because the allocation of
small areas to interviewers reduces the impact of selection
bias resulting from the selection of properties [25]. Re-
sponse rates cannot be calculated because of the lack of a
definitive gross sample: all units fulfilling the criteria of a
given quota are interchangeable within the areas.
Measures
For the present study, measures of mental health were
added to the survey for 24 monthly waves from January
2016 to December 2017. Mental health information was
self-completed by the interviewee on a laptop following
familiarisation using similar example questions. All other
questions were completed by the interviewer who
prompted the interviewee for responses and recorded do
not know/prefer not to say where needed.
Mental health was measured using three indicators:
ever diagnosis, past-year treatment and past-month dis-
tress (moderate or serious, measured using the Kessler 6
(K6) scale [26–28]); full details are given in Table 1.
The outcome measures used were (1) triggers that
prompted the most recent quit attempt, (2) the type of
support used during the attempt and (3) the outcome of
the quit attempt by the time of the survey (Table 1).
Sociodemographic measures included age (16–24, 25–
34, 35–44, 45–54, 55–64, 65 and over), gender and occupa-
tional grade (AB: higher or intermediate managerial, admin-
istrative or professional occupation; C1: supervisory or
clerical and junior managerial, administrative or professional;
C2: skilled manual workers; D: semi-skilled and unskilled
manual workers; E: state pensioners, casual and lowest grade
workers, unemployed with state benefits only [33]).
Other measures related to smoking and smoking cessa-
tion asked of all respondents included smoking status
(currently smoking daily, currently smoking non-daily,
stopped smoking in the last year), type of cigarette
(hand-rolled, manufactured, mix of both, unknown),
strengths of urges to smoke (from 0 for no urges to 5
for extremely strong urges [29, 34]) and number of quit
attempts in the past year. Those who had made at least
one quit attempt were asked whether the most recent
quit attempt was planned or not, whether they had
attempted to stop abruptly or cut down to quit and how
much time had passed since the quit attempt started (up
to 1 month, 1 to 6 months and more than 6months).
The type of support used was also included as an inde-
pendent variable in some analyses where it was coded
hierarchically as a single variable (non-evidence-based
support, NRT over the counter, e-cigarettes, prescription
medication and/or behavioural support).
Participants
In 2016 and 2017, 40,831 adults were surveyed of whom
7465 were past-year (current and recent-ex) cigarette
smokers. Of those, 6280 provided answers to all mental
health questions of whom 1993 had attempted to stop
smoking or stopped smoking in the past year. Respon-
dents who responded ‘do not know’ or ‘prefer not to say’
to any of the relevant measures were excluded, leaving
n = 1956 for analyses addressing research questions 1
and 2. To address research question 3, the main analysis
excluded those whose quit attempt had started less than
1 month ago, leaving n = 1639 respondents. Sensitivity
analysis for research question 3 included the full sample
used for research questions 1 and 2, with no restriction
on time since the quit attempt began.
Statistical analysis
The analyses plan for this and a related paper [10] were
pre-registered on the Open Science Framework (https://
osf.io/9pbv8/). Data were weighted to match the English
population profile on age, social grade, region, tenure,
ethnicity and working status within gender. The dimen-
sions are derived monthly from a combination of the
English 2011 census, Office for National Statistics mid-
year estimates and an annual random probability survey
conducted for the National Readership Survey. We cal-
culated weighted descriptives for the sample and then
ran analyses to address each of the research questions
without the weights applied.
1. Quit attempt triggers: The percentage selecting each
option as prompting the most recent quit attempt
was calculated. For prompts reported by at least 5%
overall, logistic regressions were conducted with
each prompt as outcome regressed onto mental
health status (separately for ever diagnosis, past-
year treatment and past-month distress), first
unadjusted, then adjusted for age, gender,
occupational grade, urges to smoke and time since
most recent quit attempt (collapsed into up to 6
months or more than 6 months ago), thus
replicating and extending an earlier analysis [35].
Additional unplanned analyses also included the
type of cigarette with results reported if associations
differ from the main analyses.
2. Use of support: The percentage using each type of
support during the most recent quit attempt was
calculated, followed by logistic regression with each
type of support (dummy-coded) regressed onto
mental health status (separately for ever diagnosis,
past-year treatment and past-month distress), first
unadjusted, then adjusted for age, gender,
occupational grade, urges to smoke, whether the
quit attempt was abrupt or included cutting down
first and whether it was a planned or unplanned
quit. An additional unplanned analysis included the
type of cigarette. Chi-square comparisons described
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Table 1 Measures assessing mental health, triggers for cessation
attempt, support used during and outcome of quit attempt
Mental health measures
Ever diagnosis
Since the age of 16, which of the following, if any, has a doctor or
health professional ever told you that you had? [all that apply,




d) Panic disorder or a phobia
e) Post-traumatic stress disorder
f) Psychosis
g) Personality disorder
h) Attention deficit hyperactivity disorder
i) An eating disorder
j) Alcohol misuse or dependence
k) Drug use or dependence
l) Problem gambling
m) None of these
n) Do not know
o) Prefer not to say
Categorised as ever having had a diagnosis if yes to any of a) to l).
Past-year treatment
In the last 12 months, which of the following conditions, if any,
have you had any treatment or taken any prescribed medication
for?
Response options were any conditions that had been selected in
the previous question as well as none of these, do not know and
prefer not to say.
Past-month distress
During the past 30 days, about how often, if at all, did you feel…
a) Nervous
b) Hopeless
c) Restless or fidgety
d) So depressed that nothing could cheer you up
e) That everything was an effort
f) Worthless
For each, the respondent indicated one of the following: all of the
time (scored 4), most of the time (3), some of the time (2), a little
of the time (1) and none of the time (0).
A sum score with a possible range from 0 to 24 was calculated;
scores between 5 and 12 were categorised as moderate distress
[28] and scores of 13 and higher as serious distress [26, 27].
Outcome measures
Quit attempt triggers
Q632c3a. Which of the following do you think contributed to you
making the most recent quit attempt? [all that apply, presented in
randomised order, excluding the final option]
a) Advice from a GP/health professional
a) TV advert for a nicotine replacement product
Table 1 Measures assessing mental health, triggers for cessation
attempt, support used during and outcome of quit attempt
(Continued)
b) Government TV/radio/press advert
c) Hearing about a new stop smoking treatment
d) A decision that smoking was too expensive
e) Being faced with smoking restrictions
f) I knew someone else who was stopping
g) Seeing a health warning on a cigarette packet
h) Being contacted by my local NHS Stop Smoking Services
i) Health problems I had at the time
j) A concern about future health problems
k) Attending a local stop smoking activity or event
l) Something said by family/friends/children
m) A significant birthday
n) Others (please specify)
Support used
Q632e40. Which, if any, of the following did you try to help you
stop smoking during the most recent serious quit attempt? [all that
apply, presented in randomised order excluding the final option]
a) Nicotine replacement product (e.g. patches/gum/inhaler) without a
prescription




e) Attended a Stop Smoking group
f) Attended one or more Stop Smoking one-to-one counselling/
advice/support session/s
g) Phoned a Smoking Helpline
h) A book or booklet
i) Visited www.nhs.uk/Smokefree website
j) Visited a website other than Smokefree





o) Heat-not-burn cigarette (e.g. iQOS, heatsticks)
p) Allen Carr Easyway session
q) Allen Carr Easyway book
r) The SmokeFree Formula book
s) Other book or booklet
t) Others (please specify)
As outcome variable dummy-coded as (1) ‘non-evidence-based
support’ (h, i, j, k, l, m, o, p, q, r, s, t), (2) ‘NRT over the counter’ (a),
(3) ‘e-cigarettes’ (n) and (4) ‘prescription medication and/or
behavioural support’ (b, c, d, e, f, g).
Categorised hierarchically, so where respondents used more than one
type of support, the type with evidence for higher effectiveness was
recorded [29–31]. NRT over the counter was separated from prescription
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in the analysis plan were omitted in favour of
unadjusted logistic regressions.
3. Quit success: Successful quit—defined as currently
not smoking following a quit attempt starting at
least 1 month earlier—was regressed onto support
used (coded as hierarchical single variable), mental
health status (separately for ever diagnosis, past-
year treatment and past-month distress), age,
gender, occupational grade, urges to smoke, mean
number of past-year quit attempts, type of cigarette
(manufactured only versus roll-your-own, mix,
unknown) and time since quit attempt started,
using unadjusted and adjusted logistic regressions
again replicating and extending an earlier analysis
[29]. A final model consisted of the adjusted logistic
regression with additional interaction terms for
mental health status and support used. Sensitivity
analyses in addition to the pre-specified analysis
repeated the main analyses using abstinence from
smoking after a quit attempt without restriction on
the time since the quit attempt started to increase
comparability with research questions 1 and 2 and
other papers using the Smoking Toolkit Study data
[29, 30, 36].
Where associations were not statistically significant,
Bayes factors (BFs) were calculated to determine whether
results were supportive of the null hypothesis, the alterna-
tive hypothesis, or insensitive to detect a difference. We
used a conservative approach with the alternative hypoth-
esis represented by a half-normal distribution. Expected
effect size for mental health conditions was set to odds
ratio (OR) = 0.64 based on previous studies that have
suggested a negative association between mental health
conditions and smoking cessation [5]. Expected effect
sizes were set to 0.96 for NRT over the counter [29] and
to 1.95 for e-cigarettes [30]. For prescription medication
and/or behavioural support, in two separate calculations,
smaller (1.61 [29]) and larger effect sizes (3.25 [29]) were
used to reflect varied estimates in the literature. BFs > 3
can be interpreted as evidence for the alternative hypoth-
esis (and against the null), BFs < 1/3 as evidence for the
null hypothesis and BFs between 1/3 and 3 as evidence
that the data are insensitive to distinguish the alternative
hypothesis from the null.
Results
Four in ten respondents (40.2%) reported ever having
had a mental health diagnosis since the age of 16, 25.9%
reported treatment for a mental health problem in the
past year and 40% reported moderate or serious past-
month distress (Table 2). For the prevalence of individ-
ual diagnoses, see Additional File 1, Table S1.
All age groups were represented with those aged 65
and over the smallest group; just over half of the sample
were men, and the full range of occupational grades was
represented. Two thirds (67.4%) were daily smokers, and
just over a fifth (21.7%) had stopped smoking in the last
year. About half (48.7%) smoked or had smoked roll-
your-own cigarettes only or as well as manufactured cig-
arettes. On average, respondents had made just under 2
quit attempts in the past year. Almost half (47.2%) of the
most recent quit attempts had started 1 to 6months
ago, 36.8% started more than 6months ago and the
remaining 16.1% had started within the last month.
About half (51.7%) of these quit attempts had been un-
planned, and a similar proportion (53.8%) had stopped
without cutting down. On average, respondents experi-
enced slight to moderate urges to smoke (Table 2).
Quit attempt triggers
Overall, the three most frequently reported triggers were
‘concern about future health’ (36.5%), ‘health problems I
had at the time’ (19.7%) and ‘a decision that smoking
was too expensive’ (19.0%). Further reasons with more
than 5% agreement were ‘something said by friends/fam-
ily (17.0%), ‘general practitioner (GP)/health professional
advice’ (13.5%), ‘others’ (5.7%) and ‘knew someone else
who was stopping’ (5.6%, Tables 3 and 4).
In adjusted analysis, respondents who have ever had a
diagnosis, had past-year treatment or had serious past-
month distress were more likely than those without to
select ‘health problems I had at the time’. Respondents
with moderate or serious distress were additionally
more likely to select ‘something said by family/friends/
Table 1 Measures assessing mental health, triggers for cessation
attempt, support used during and outcome of quit attempt
(Continued)
medication as NRT without support appears to be a weaker option
[30–32]. Numbers were too small to separate group 4 further as initially
planned.
Quit success
How long did your most recent serious quit attempt last before
you went back to smoking?
a) Still not smoking
b) Less than a day
c) Less than a week
d) More than 1 week and up to a month
e) More than 1month and up to 2 months
f) More than 2 months and up to 3 months
g) More than 3months and up to 6 months
h) More than 6months and up to a year
If respondents were not smoking at the time of the survey (a), they
were categorised as having made a successful attempt. This was
restricted to those whose attempt started at least 1 month ago for
some analysis.
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children’ than those without distress (Tables 3 and 4).
In unplanned analyses including the type of cigarette,
those who have ever had a diagnosis were more likely
to select ‘too expensive’ (adjusted OR = 1.29, 95% confi-
dence interval (CI) 1.01 to 1.64, p = 0.041). Unadjusted
logistic regression models for all variables are provided
in Additional file 1, Tables S2 and S3.
The remaining reasons were selected by fewer than 4%
of respondents: seeing a health warning on a cigarette
packet, 3.3%; being faced with smoking restrictions,
3.1%; pregnancy, 3.1%; (just) decided to quit, 2.3%; TV
advert for a nicotine replacement product, 2.2%; a sig-
nificant birthday, 1.5%; government TV/radio/press ad-
vert, 1.2%; being contacted by my local National Health
Table 2 Sample description overall and by ever diagnosis, past-year treatment and past-month distress, weighted
Characteristic Total Ever diagnosis Past-year treatment Past-month distress
No Yes No Yes None Moderate Serious
Ever diagnosis, % 40.2 – – 0 100 21.4 59.2 90.6
Past-year treatment, % 25.9 – 64.5 – – 9.9 39.6 75.3
Past-month distress, % Moderate 28.3 19.3 41.6 23.1 43.3 – – –
Serious 11.7 1.8 26.4 3.9 33.8 – – –
Age, % 16–24 19.0 18.2 20.2 18.6 20.1 14.4 25.3 27.5
25–34 26.8 25.3 29.0 26.0 29.0 25.5 29.0 27.9
35–44 20.2 19.9 20.7 20.1 20.7 19.9 21.2 19.7
45–54 17.1 17.4 16.5 17.3 16.5 19.6 12.7 14.3
55–64 10.2 10.7 9.4 10.2 10.0 11.6 8.0 8.6
≥ 65 6.7 8.5 4.0 7.8 3.7 8.9 3.9 2.0
Gender, %1 Men 51.8 58.4 42.0 56.8 37.5 55.3 50.8 36.5
Women 48.2 41.6 58.0 43.2 62.5 44.7 49.2 63.5
Occupational grade, %2 AB 17.9 20.4 14.2 19.8 12.4 20.1 16.4 10.3
C1 25.1 26.0 23.7 26.6 21.1 26.7 23.7 20.6
C2 25.4 28.0 21.7 27.0 20.9 25.8 26.3 21.8
D 18.2 17.5 19.2 17.8 19.4 18.0 17.3 21.4
E 13.3 8.0 21.1 8.8 26.1 9.4 16.3 25.9
Smoking, % Daily 67.4 67.1 67.9 67.3 67.8 66.8 66.9 71.6
Non-daily 10.9 11.5 10.0 11.3 10.0 10.9 11.0 10.3
Stopped last
year
21.7 21.4 22.1 21.5 22.2 22.3 22.0 18.1
Type of cigarette, % Manufactured 47.4 51.7 41.1 50.4 39.1 50.8 44.5 37.3
Roll-your-own 43.0 5.3 6.3 5.0 7.6 4.7 6.9 8.0
Mix 5.7 39.0 48.9 40.3 50.6 40.2 45.8 50.5
Unknown 3.9 4.0 3.7 4.3 2.6 4.3 2.9 4.2
Time since most recent quit attempt,
%
< 1month 16.1 15.7 16.6 15.1 18.7 16.1 15.6 16.8
1 to 6 months 47.2 46.6 48.0 47.5 46.0 44.8 50.8 50.8
> 6 months 36.8 37.7 35.4 37.3 35.3 39.1 33.7 32.4
Unplanned quit attempt, % 51.7 51.3 52.2 52.2 50.1 51.8 49.1 57.6
Stopped without cutting down, % 53.8 52.5 55.7 54.6 51.4 54.4 51.9 54.7
































Unweighted n = 1956
1A provided third option was not used by anyone in the included sample
2AB: higher or intermediate managerial, administrative or professional occupation; C1: supervisory or clerical and junior managerial, administrative or professional;
C2: skilled manual workers; D: semi-skilled and unskilled manual workers; E: state pensioners, casual and lowest grade workers, unemployed with state
benefits only
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Service (NHS) Stop Smoking Services, 0.8%; hearing
about a new stop smoking treatment, 0.7%; and attend-
ing a local stop smoking activity or event, 0.7%.
Support used
The most popular support used was non-evidence-based
(42.0%), followed by e-cigarettes (35.2%) and NRT over
the counter (12.0%). Few had used prescription medica-
tion (7.9%), behavioural support (2.0%) or a combination
of those two (0.9%). The last three groups were collapsed
for further analyses (prescription medication and/or be-
havioural support, 10.8%). Respondents who have ever
had a mental health diagnosis or moderate or serious
past-month distress were less likely to have used NRT
over the counter than those without those indicators of
a mental health problem (Table 5). Respondents with
past-year treatment and those with serious distress were
more likely to have used prescription medication and/or
behavioural support. Use of non-evidence-based support
and of e-cigarettes was similar across the groups
(Table 5). In unplanned analyses including the type
of cigarette, those who have ever had a diagnosis
were more likely to have used prescription and/or
behavioural support than those without (OR = 1.37,
95% CI 1.01 to 1.86, p = 0.046). Unadjusted logistic
regression models for all variables are provided in
Additional file 1, Table S4.
Quit success
Overall, 18.3% of those who had started their quit
attempt at least 1 month before the survey were still ab-
stinent; this rose to 19.1% of those who had started their
Table 3 Associations between mental health and triggers for quit attempts
Concern re future health Current health problem Too expensive Something said by friends/family
%1 adjOR, 95% CI
2 p %1 adjOR, 95% CI
2 p %1 adjOR, 95% CI
2 p %1 adjOR, 95% CI
2 p
Ever diagnosis
No 36.2 Ref 17.5 Ref 18.0 Ref 16.1 Ref
Yes 37.0 1.16, 0.95–1.41 0.15 23.5 1.55, 1.23–1.97 < 0.001 20.4 1.20, 0.94–1.52 0.14 18.4 1.21, 0.94–1.56 0.15
Past-year treatment
No 36.7 Ref 17.7 Ref 18.9 Ref 16.5 Ref
Yes 35.9 1.10, 0.88–1.38 0.40 25.4 1.52, 1.18–1.97 0.001 19.4 1.05, 0.80–1.37 0.74 18.5 1.13, 0.85–1.49 0.41
Past-month distress
None 36.6 Ref 18.2 Ref 18.2 Ref 14.2 Ref
Moderate 37.5 1.15, 0.92–1.43 0.22 20.3 1.25, 0.96–1.63 0.099 21.0 1.15, 0.88–1.49 0.30 21.5 1.49, 1.13–1.96 0.005
Serious 33.6 1.06, 0.77–1.45 0.71 25.8 1.72, 1.21–2.43 0.002 18.4 1.06, 0.73–1.54 0.77 20.2 1.52, 1.03–2.22 0.034
Unweighted n = 1956
Bold figures indicate that the confidence interval does not include 1
1Weighted % who reported each trigger, those with > 5% overall only
2Logistic regressions unweighted, adjusted for age, gender, occupational grade, urges to smoke, time since most recent quit attempt
Table 4 Associations between mental health and triggers for quit attempts continued
GP/health professional advice Others Knew someone else who was stopping
%1 adjOR, 95% CI
2 p %1 adjOR, 95% CI
2 p %1 adjOR, 95% CI
2 p
Ever diagnosis
No 14.2 Ref 5.4 Ref 5.4 Ref
Yes 12.4 0.86, 0.65–1.14 0.30 6.2 1.33, 0.89–2.00 0.16 5.7 1.07, 0.70–1.62 0.76
Past-year treatment
No 13.5 Ref 5.7 Ref 5.4 Ref
Yes 13.5 0.99, 0.73–1.36 0.96 5.7 1.21, 0.78–1.89 0.40 5.9 1.19, 0.75–1.89 0.46
Past-month distress
None 14.8 Ref 5.5 Ref 5.7 Ref
Moderate 10.8 0.83, 0.61–1.14 0.26 6.4 1.38, 0.89–2.13 0.155 5.4 0.86, 0.54–1.37 0.54
Serious 13.5 1.02, 0.66–1.56 0.94 5.3 1.18, 0.62–2.25 0.61 4.5 0.87, 0.44–1.73 0.70
Unweighted n = 1956
Bold figures indicate that the confidence interval does not include 1
1Weighted % who reported each trigger, those with > 5% overall only
2Logistic regressions unweighted, adjusted for age, gender, occupational grade, urges to smoke, time since most recent quit attempt
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quit attempt at any time including less than 1 month be-
fore the survey. Unadjusted logistic regression models for
all variables are provided in Additional file 1, Table S5.
For analyses including past-month distress, we could
not include an interaction term for support used and
distress as no respondent with serious distress had quit
successfully with NRT over the counter (Additional file 1,
Table S6). For ever diagnosis and past-year treatment,
interaction terms were included.
In adjusted analyses, quit success was not significantly
associated with ever having had a mental health diagno-
sis, past-year treatment or past-month distress (Table 6),
with moderate evidence to support the null hypothesis
compared with a modest negative association (OR =
0.65) on ever diagnosis and treatment (BFs 0.20 and
0.26) and data insensitive on past-month distress (BFs
0.70 and 0.41).
Compared with non-evidence-based support, e-cigarettes
were positively associated with quit success (both of at least
1 month and of any length). The association was similar
across the three models that separately included the differ-
ent indicators of mental health (Table 6). Prescription
medication and/or behavioural support was also signifi-
cantly associated with greater quit success of at least
1 month when including past-month distress (OR 1.69).
The association was similar but non-significant in models
including ever diagnosis or past-year treatment instead of
distress (OR 1.68 and OR 1.68). Across all models, BFs
Table 6 Adjusted associations with quit success using three different indicators for mental health (ever diagnosis, past-year
treatment, past-month distress)
Quit > 1 month Quit any length
Success rate, %1 OR, 95% CI p Success rate, %1 OR, 95% CI p
Ever diagnosis
No 18.3 Ref 18.8 Ref
Yes 18.1 1.14 (0.83–1.57) 0.43 19.6 1.23 (0.94–1.62) 0.13
Support used
Non-evidence-based 16.4 Ref 16.5 Ref
NRT over the counter 14.1 1.06 (0.62–1.81) 0.84 16.7 1.32 (0.85–2.07) 0.22
E-cigarettes 21.5 2.25 (1.59–3.18) < 0.001 23.0 2.21 (1.64–2.98) < 0.001
Prescription and/or
behavioural support
18.9 1.68 (1.00–2.84) 0.051 18.8 1.46 (0.92–2.31) 0.11
Past-year treatment
No 18.3 Ref 19.2 Ref
Yes 18.0 1.13 (0.78–1.62) 0.52 18.9 1.08 (0.80–1.48) 0.61
Support used2
Non-evidence-based Ref Ref
NRT over the counter 1.05 (0.61–1.80) 0.86 1.31 (0.84–2.05) 0.24
E-cigarettes 2.24 (1.58–3.17) < 0.001 2.21 (1.64–2.98) < 0.001
Prescription and/or
behavioural support
1.68 (1.00–2.84) 0.051 1.48 (0.93–2.34) 0.099
Past-month distress
No 19.9 Ref 20.9 Ref
Moderate 16.2 0.88 (0.61–1.27) 0.49 17.1 0.89 (0.65–1.21) 0.46
Serious 15.3 1.11 (0.66–1.87) 0.69 14.8 0.89 (0.57–1.40) 0.61
Support used2
Non-evidence-based Ref Ref
NRT over the counter 1.06 (0.62–1.82) 0.84 1.29 (0.83–2.03) 0.26
E-cigarettes 2.25 (1.59–3.18) < 0.001 2.21 (1.64–2.97) < 0.001
Prescription and/or
behavioural support
1.69 (1.01–2.86) 0.047 1.50 (0.95–2.38) 0.085
Unweighted n = 1956 for quit any length, n = 1639 for quit success > 1 month
Adjusted for age, gender, occupational grade, urges to smoke, time since quit attempt started, number of quit attempts in the past year and type of cigarette
NRT nicotine replacement therapy, OTC over-the-counter (without prescription)
1Weighted % with the relevant outcome, logistic regressions unweighted
2Success rates as shown in first section of table
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revealed that a positive association between prescription
medication and/or behavioural support and quit success
was more likely than the null. Depending on the out-
come (abstinence of at least 1 month or any length)
and the magnitude of the expected positive associ-
ation, BFs ranged from 1.35 (anecdotal evidence) to
3.82 (moderate evidence). NRT over the counter was
not significantly associated with quit success, and the
BF (0.96) indicated anecdotal evidence for the null
hypothesis. There were no significant interactions be-
tween ever diagnosis and support used (p = 0.96) or
between past-year treatment and support used (p =
0.99) in relation to quit success. Associations between
quit success and mental health indicators or support
used remained similar with and without interactions
included.
Discussion
Among smokers with and without mental health problems,
the most frequent triggers of quit attempts were concerns
about current and future health, cost of smoking, some-
thing said by friends/family and advice from a GP or health
professional. There were small differences in that current
health and comments from friends/family were a more fre-
quent trigger for those with mental health problems. There
was some indication that during a quit attempt, those with
mental health problems were less likely to have used NRT
over the counter and more likely to have used prescription
medication or behavioural support. There was no differ-
ence in the use of e-cigarettes during a quit attempt and e-
cigarettes conferred a benefit over non-evidence-based
support. Smokers with mental health problems were as
likely to be successful in their quit attempt as smokers
without mental health problems, and type of support was
not differentially associated with success in those with and
without mental health problems.
Quit attempt triggers appear to have changed over
time. Compared with a study which used data from 2009
to 2012 from the same survey [35], concerns about fu-
ture health (2009–2012, 20.6%; 2016–2017, 36.1%) and
current health problems (2009–2012, 11.8%; 2016–2017,
20.8%) appear to have become more common. In the
earlier study, advice from a GP or health professional
was the top reason (24.5%); this had fallen to fifth place
in the more recent data (14.8%) overall and was no more
common among those with mental health problems.
The rating of triggers highlights where changes could
help increase quit attempts. The decline in the relevance
of healthcare professionals’ advice may negatively affect
quitting among smokers with mental health problems.
Brief advice has been shown to improve long-term quit
rates in the general population of smokers [37, 38], and
guidelines for healthcare professionals on providing very
brief advice on smoking at every opportunity [39] may
need to be emphasised. The present results also indicate
that media campaigns and smoking cessation services ap-
pear not to be widely cited by smokers, which may partly
be due to a lack of funding in the years of data collection
[40, 41]. To help reduce inequalities, campaigns should be
developed and targeted to be particularly effective for
smokers with mental health problems. Stop smoking ser-
vices used to be available across England and the services
were able to help reduce inequalities [42]; however, ser-
vices have been reduced considerably in recent years [43].
Evidence-based support in the form of medication and be-
havioural support provided by trained practitioners needs
to be available for all those who need them [44]. Having
professionals who can lead on supporting smokers with
mental health problems may also be beneficial [45].
It is encouraging that smokers with recent treatment
for a mental health problem or with distress were more
likely to have used support in the form of prescription
medication or behavioural support which has been
shown to be effective in the general population and
those with severe mental health problems [21, 22]. This
will be partly because smokers who have recently been
treated for a mental health problem are likely to have
had more frequent contact with healthcare providers
than other smokers which increases the overall chance
of being offered treatment [46].
Reviews of trials found varenicline and bupropion to be
efficacious for smoking cessation in smokers with mental
health problems [21, 22], and an analysis of Smoking
Toolkit Study data collected from 2006 to 2018 also found
varenicline to be associated with higher success rates [30].
In the present study, there was anecdotal to moderate
evidence of an effect of prescription medication (which in-
cluded varenicline, bupropion and NRT). Grouping differ-
ent prescription medication options and grouping them
with different levels of behavioural support may have
attenuated effects. As in the present study, the previous
survey analysis found e-cigarettes to be associated with in-
creased success [30].
Systematic reviews indicate that, with the exception of
stop smoking services that can compensate for lower
quit rates in disadvantaged populations through in-
creased reach, individual-level behavioural and pharma-
cological smoking cessation interventions often do not
reduce socio-economic inequalities in smoking [42, 47].
Evidence on interventions that help reduce inequalities
related to mental health is sparse as is evidence on the
effectiveness of e-cigarettes for smoking cessation or re-
duction among smokers with mental health problems. A
recent systematic review identified no controlled trials
and only four small single-group pre-post studies which
suggested some benefit [48]. The present findings pro-
vide some evidence on the likely impact of e-cigarettes
on inequalities caused by smoking. That they were the
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type of support associated with the greatest increase in suc-
cess rates, used to a similar extent and with similar success
by smokers with and without mental health problems, indi-
cates that e-cigarettes used in quit attempts currently are
more likely to positively affect inequalities than other smok-
ing cessation interventions. However, they may have further
potential to reduce inequalities if their reach or effective-
ness among those with mental health problems can be in-
creased. Better reach could be supported by improved
understanding in the general public and among health pro-
fessionals that e-cigarettes provide a less harmful alternative
to smoking [49, 50] and are effective for quitting smoking
[51, 52], particularly in combination with behavioural sup-
port as provided by stop smoking services [51, 53].
The present study addresses a lack of evidence on ways
to improve smoking cessation among the underserved but
large group of smokers with mental health problems. It is
the first study to provide population-level evidence on trig-
gers of quit attempts; type of support used, including e-
cigarettes; and outcomes of quit attempts in smokers with
mental health problems compared with those without.
Limitations of the study include that the data collection
was cross-sectional and information therefore retrospect-
ive. As a household survey, people too unwell to partici-
pate or in institutions were excluded, so the findings may
not generalise to those experiencing severe mental health
problems. Due to the sampling strategy used, a response
rate cannot be calculated; however, samples obtained have
been shown to be similar in sociodemographic compos-
ition, smoking rates and consumption to the general
population [24, 54]. Smoking abstinence was not bio-
chemically validated, but previous work has shown that
accurate estimates of smoking prevalence can be derived
from self-report in population surveys [55–57]. The pro-
portion of respondents who had used prescription medi-
cation or behavioural support was too small to assess the
effectiveness of different medications or the separate effect
of behavioural support. Although mental health status was
self-reported, the use of three different indicators of men-
tal health strengthens confidence in the findings. The
study used a long-standing data source with established
analysis approaches and a pre-registered analysis plan.
Conclusions
In conclusion, smokers with mental health problems fre-
quently reported that quit attempts were triggered by con-
cerns around health, costs of smoking and comments from
those close to them. Smokers with mental health problems
were more likely to have used evidence-based support in
the form of prescription medication or behavioural support
and not NRT without prescription. E-cigarettes were asso-
ciated with increased success and they were used similarly
across those with and without mental health problems, in-
dicating that improved uptake of e-cigarettes for smoking
cessation among smokers with mental health problems
could help address inequalities.
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